Lantheus Holdings

LNTH US Health Care Health Care Supplies
S&P 400
$100.25
-0.14%
Delayed · cached 15 min

Fair value analysis

LNTH
Lantheus Holdings
Health CareHealth Care Supplies
$100.25
Close used for this calculation
$69.73Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
58/100
Profitability23/25
Returns10/25
Balance Sheet15/25
Efficiency10/25
Growth12/25
Good
Quality radar
58Prof.23/25Ret.10/25Eff.10/25B.Sht15/25Growth12/25

Consensus fair value

$69.73
Above FV
▼ -30.4% against the close used
Model range $38.61 – $100.11
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear$38.61Fair value$69.73Bull$100.11
FairClose
52-week traded range
52W low $50.1152W high $110.94

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Lantheus Holdings closed at $100.25, 43.8% above the consensus fair value of $69.73 drawn from 8 valuation models.

Financial DNA score 58/100 — Good. P/E of 29.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
$67.69
-32.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
$38.61
-61.5%
√(22.5 × EPS × BVPS)
EPS=3.41, BVPS=19.43 · outside Graham range (P/E 29.4, P/B 5.2) — asset-light, treat as a rough floor
P/E Fair Value
$68.20
-32.0%
EPS × 20x (sector P/E)
EPS=3.41, Sector P/E=20x
Peter Lynch (PEG)
$77.00
-23.2%
EPS × Growth% (PEG = 1 is fair)
EPS=3.41, g=22.6%
EV/EBITDA
$100.11
-0.1%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=380.93M
Book Value (P/B)
$57.31
-42.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=19.43, ROE=17.8%, g=6%, r=10%
Reverse DCF
$100.25
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 12.3% | Historical: 22.6%
Margin of Safety
$43.63
-56.5%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=58.17, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.